Search Instructions:
* Filter the ENTIRE resource library: Choose a OR a to sort all resources.
* Choose Search Items : to filter one collection or perform complex queries.
* Choose Browse by Topic to search by one or more Topics.
Browse Items (1467 total)
-
Creator: Wu, Zhiwei, Yaling Hu, Miao Xu, Zhen Chen, Wanqi Yang, Zhiwei Jiang, Minjie Li, Hui Jin, Guoliang Cui, Panpan Chen, Lei Wang, Guoqing Zhao, Yuzhu Ding, Yuliang Zhao, and Weidong Yin.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-03
Description: A vaccine against COVID-19 is urgently needed for older adults, in whom morbidity and mortality due to the disease are increased. We aimed to assess the safety, tolerability, and immunogenicity of a candidate COVID-19 vaccine, CoronaVac, containing… -
Creator: the COVE Study Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-04
Description: Vaccines are needed to prevent coronavirus disease 2019 (Covid-19) and to protect persons who are at high risk for complications. The mRNA-1273 vaccine is a lipid nanoparticle–encapsulated mRNA-based vaccine that encodes the prefusion stabilized… -
Creator: Lee, Myoung-Hwa, Daniel P. Perl, Govind Nair, Wenxue Li, Dragan Maric, Helen Murray, Stephen J. Dodd, Alan P. Koretsky, Jason A. Watts, Vivian Cheung, Eliezer Masliah, Iren Horkayne-Szakaly, Robert Jones, Michelle N. Stram, Joel Moncur, Marco Hefti,…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-04
Description: We conducted postmortem high-resolution magnetic resonance imaging (magnetic resonance microscopy) of the brains of patients with coronavirus disease 2019 (Covid-19) (median age, 50 years) and histopathological examination that focused on… -
Creator: Schafer, Adam, Rui Xiong, Laura Cooper, Raghad Nowar, Hyun Lee, Yangfeng Li, Benjamin E. Ramirez, Norton P. Peet, Michael Caffrey, Gregory R. J. Thatcher, Erica Ollmann Saphire, Han Cheng, and Lijun Rong.
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-04
Description: Many small molecules have been identified as entry inhibitors of filoviruses. However, a lack of understanding of the mechanism of action for these molecules limits further their development as anti-filoviral agents. Here we provide evidence that… -
Creator: Dugdale, C. M., D. M. Rubins, H. Lee, S. M. McCluskey, E. T. Ryan, C. N. Kotton, R. M. Hurtado, A. L. Ciaranello, M. B. Barshak, D. S. McEvoy, S. B. Nelson, N. Basgoz, J. E. Lazarus, L. C. Ivers, J. L. Reedy, K. M. Hysell, J. E. Lemieux, H. M.…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-10
Description: Isolation of hospitalized persons under investigation (PUIs) for COVID-19 reduces nosocomial transmission risk. Efficient PUI evaluation is needed to preserve scarce healthcare resources. We describe the development, implementation, and outcomes of… -
Creator: the Oxford University Hospitals Staff Testing Group
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-11
Description: The relationship between the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the risk of subsequent reinfection remains unclear.Example only: NETEC provides this item for reference purposes but does not endorse its content. Newer versions may be in place at the providing institution.
-
Creator: NETEC
Subject: Research
Item Type: Webinar
Date Last Updated: 2021-02-12
Description: In this webinar, we will define mutation and variant as they relate to SARS-CoV-2, discuss the importance of the current variants and mutations including future predictions surrounding the epidemiology of spread and modeling and describe what is… -
Creator: DiLorenzo, M. A., C. A. Baker, J. J. Herstein, L. Evans, J. J. Lowe, S. G. Gibbs, and N. Bhadelia.
Subject: Emergency Management
Item Type: Publication
Date Last Updated: 2021-02-15
Description: In response to the 2013-2016 Ebola virus disease outbreak, the US government designated certain healthcare institutions as Ebola treatment centers (ETCs) to better prepare for future emerging infectious disease outbreaks. This study investigated ETC… -
Creator: Liu, Yang, Jianying Liu, Hongjie Xia, Xianwen Zhang, Camila R. Fontes-Garfias, Kena A. Swanson, Hui Cai, Ritu Sarkar, Wei Chen, Mark Cutler, David Cooper, Scott C. Weaver, Alexander Muik, Ugur Sahin, Kathrin U. Jansen, Xuping Xie, Philip R.…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-17
Description: BNT162b2 is a nucleoside-modified RNA vaccine expressing the full-length prefusion spike glycoprotein (S) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In a randomized, placebo-controlled clinical trial involving approximately… -
Creator: Wu, Kai, Anne P. Werner, Matthew Koch, Angela Choi, Elisabeth Narayanan, Guillaume B. E. Stewart-Jones, Tonya Colpitts, Hamilton Bennett, Seyhan Boyoglu-Barnum, Wei Shi, Juan I. Moliva, Nancy J. Sullivan, Barney S. Graham, Andrea Carfi, Kizzmekia S.…
Subject: Research
Item Type: Publication
Date Last Updated: 2021-02-17
Description: The mRNA-1273 vaccine against SARS-CoV-2 elicited high neutralizing-antibody titers in phase 1 trial participants and has been shown to be highly efficacious in preventing symptomatic Covid-19 disease and severe disease.